Trial Profile
Study of the Effect of Sitagliptin on the Hormonal Responses to Macronutrient Ingestion in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2011 Planned end date changed from 1 Jun 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.